linezolid
DESCRIPTION
LINEZOLID. The discovery and clinical development of effective antibiotics is most remarkable achievement over the past 60 years. Since the introduction of the sulphonamides in 1936, researchers have developed a range of antibiotic classes. - PowerPoint PPT PresentationTRANSCRIPT
![Page 1: LINEZOLID](https://reader038.vdocuments.net/reader038/viewer/2022110102/568142b1550346895daef2be/html5/thumbnails/1.jpg)
![Page 2: LINEZOLID](https://reader038.vdocuments.net/reader038/viewer/2022110102/568142b1550346895daef2be/html5/thumbnails/2.jpg)
![Page 3: LINEZOLID](https://reader038.vdocuments.net/reader038/viewer/2022110102/568142b1550346895daef2be/html5/thumbnails/3.jpg)
LINEZOLIDLINEZOLID
![Page 4: LINEZOLID](https://reader038.vdocuments.net/reader038/viewer/2022110102/568142b1550346895daef2be/html5/thumbnails/4.jpg)
The discovery and clinical development of effective antibiotics
is most remarkable achievement over the past 60 years.
. Since the introduction of the sulphonamides in 1936, researchers have developed a range of antibiotic classes.
![Page 5: LINEZOLID](https://reader038.vdocuments.net/reader038/viewer/2022110102/568142b1550346895daef2be/html5/thumbnails/5.jpg)
Until recently, however all new antibiotics introduced over the past 35 years have been structural modifications of existing antibiotic classes.
![Page 6: LINEZOLID](https://reader038.vdocuments.net/reader038/viewer/2022110102/568142b1550346895daef2be/html5/thumbnails/6.jpg)
.
The oxazolidinones represent the first truly new class of antibacterial agents. Approved in 2000 by the US FDA.
Linezolid has a unique mechanism of antibacterial action.
![Page 7: LINEZOLID](https://reader038.vdocuments.net/reader038/viewer/2022110102/568142b1550346895daef2be/html5/thumbnails/7.jpg)
.
![Page 8: LINEZOLID](https://reader038.vdocuments.net/reader038/viewer/2022110102/568142b1550346895daef2be/html5/thumbnails/8.jpg)
![Page 9: LINEZOLID](https://reader038.vdocuments.net/reader038/viewer/2022110102/568142b1550346895daef2be/html5/thumbnails/9.jpg)
Linezolid is the first of a new class of anti microbial agents, the Oxazolidinones, whose mechanism of action differs from that of existing agents.
![Page 10: LINEZOLID](https://reader038.vdocuments.net/reader038/viewer/2022110102/568142b1550346895daef2be/html5/thumbnails/10.jpg)
Cross resistance to other antimicrobials is therefore less likely and has not been shown till date.
. It is approved US FDA in adults (April 2000) and children (December 2002) for the treatment of Gram Positive bacteria.
![Page 11: LINEZOLID](https://reader038.vdocuments.net/reader038/viewer/2022110102/568142b1550346895daef2be/html5/thumbnails/11.jpg)
![Page 12: LINEZOLID](https://reader038.vdocuments.net/reader038/viewer/2022110102/568142b1550346895daef2be/html5/thumbnails/12.jpg)
It disrupts bacterial growth by inhibiting the initiation process in protein synthesis. It binds to a site on the bacterial 23s ribosomal RNA of the 50s subunit, preventing the formation of functional 70s initiation complex which is an essential component of the bacterial translation process.
![Page 13: LINEZOLID](https://reader038.vdocuments.net/reader038/viewer/2022110102/568142b1550346895daef2be/html5/thumbnails/13.jpg)
![Page 14: LINEZOLID](https://reader038.vdocuments.net/reader038/viewer/2022110102/568142b1550346895daef2be/html5/thumbnails/14.jpg)
This site of inhibition process occurs earlier in the initiation process than other protein synthesis inhibitors that interfere with the elongation process.
![Page 15: LINEZOLID](https://reader038.vdocuments.net/reader038/viewer/2022110102/568142b1550346895daef2be/html5/thumbnails/15.jpg)
Absorption: Well absorbed orally irrespective of timing of meal
Absorption: Well absorbed orally irrespective of timing of meal
.
Bioavailability: 100%Bioavailability: 100%
![Page 16: LINEZOLID](https://reader038.vdocuments.net/reader038/viewer/2022110102/568142b1550346895daef2be/html5/thumbnails/16.jpg)
.
Half Life:Half Life: Preterm neonate < 1 week: 5.6 hrs. Term neonate < 1 week: 3 hrs. Term neonate > 1 week: 1.5 hrs. Infants: 1.8 hrs Children: 3 + 1.1 hrs Adolescent: 4.1 hrs
Preterm neonate < 1 week: 5.6 hrs. Term neonate < 1 week: 3 hrs. Term neonate > 1 week: 1.5 hrs. Infants: 1.8 hrs Children: 3 + 1.1 hrs Adolescent: 4.1 hrs
![Page 17: LINEZOLID](https://reader038.vdocuments.net/reader038/viewer/2022110102/568142b1550346895daef2be/html5/thumbnails/17.jpg)
.
Maximum Plasma concentration is reached within 1 to 2 hrs.
Distributes readily to well perfused area
![Page 18: LINEZOLID](https://reader038.vdocuments.net/reader038/viewer/2022110102/568142b1550346895daef2be/html5/thumbnails/18.jpg)
.
Metabolism: It is primarily metabolized by oxidation of the morphine ring which results in two inactive ring-opened carboxylic acid metabolites
A) aminoethoxyacetic acid(B) hydroxyethyl glycine
![Page 19: LINEZOLID](https://reader038.vdocuments.net/reader038/viewer/2022110102/568142b1550346895daef2be/html5/thumbnails/19.jpg)
.
Excretion: Non renal clearance accounts for about 65% of total clearance.
Approximately 30% of the dose appears in urine as Linezolid, 40% as metabolite B and 10% as metabolite A
![Page 20: LINEZOLID](https://reader038.vdocuments.net/reader038/viewer/2022110102/568142b1550346895daef2be/html5/thumbnails/20.jpg)
.
Aerobic and facultative Gram positive
microorganismsEnterococcus faecium (vancomycin resistant strains only)Staphylococcus aureus ( including
methicillin resistantstrain)Streptococcus agalactiaeStreptococcus pneumoniae
( penicillin susceptible strains only)Strptococcus pyrogenes
![Page 21: LINEZOLID](https://reader038.vdocuments.net/reader038/viewer/2022110102/568142b1550346895daef2be/html5/thumbnails/21.jpg)
.
Aerobic and facultative Gram positive microorganisms
Aerobic and facultative Gram-negative microorganisms
Enterococcus faecalis (including vancomycin-resistan strains)Enterococcus faecalis (vancomycin-susceptible strains)Staphylococcus epidermidis (including methicillin- resistant strains)Staphylococcus haemolyticus.Streptococcus pneumoniae (penicillin-resistant strains)Viridans group streptococci
Pasteurella multocida
![Page 22: LINEZOLID](https://reader038.vdocuments.net/reader038/viewer/2022110102/568142b1550346895daef2be/html5/thumbnails/22.jpg)
.
Vancomycin-Resistant Enterococcus faecium
infections, including cases with concurrent bacteremia Nosocomial pneumonia caused by staphylococcus aureus (methicillin susceptible and resistant strains), or streptococcus pneumoniae (penicillin susceptible strains).
Combination therapy may be clinically indicated if the documented or presumptive pathogens include Gram- negative organisms.
![Page 23: LINEZOLID](https://reader038.vdocuments.net/reader038/viewer/2022110102/568142b1550346895daef2be/html5/thumbnails/23.jpg)
.
Complicated skin and skin structure infections caused by staphylococcus aureus (methicillin-susceptible and resistant strains), streptococcus pyogenes, or streptococcus agalactiae
Uncomplicated skin and skin structure infections caused by staphylococcus aureus (methicillin-susceptible only) or streptococcus pyogenes
![Page 24: LINEZOLID](https://reader038.vdocuments.net/reader038/viewer/2022110102/568142b1550346895daef2be/html5/thumbnails/24.jpg)
.
Community-acquired pneumonia caused by Streptococcus pneumoniae (penicillin-susceptible strains only),including cases with concurrent bacteremia, or staphylococcus aureus (methicillin-susceptible strains).
![Page 25: LINEZOLID](https://reader038.vdocuments.net/reader038/viewer/2022110102/568142b1550346895daef2be/html5/thumbnails/25.jpg)
.
INFECTION DAILY DOSE DURATION OF THERAPY
complicated skin and skin structure infections
10MG/KG Q8H 10-14 DAYScommunity acquired pneumonia including concurrentbacteremia
Nosocomial pneumonia
vancomycin-resistant Enterococcus Faeciumin fections, including concurrent bacteremia
10MG/KG Q8H 14-28 DAYS
uncomplicated skin and skin structure infections.
<5 yrs 10 mg/kg q8h10 -14 days5-11 yrs 10 mg/kg q12h
![Page 26: LINEZOLID](https://reader038.vdocuments.net/reader038/viewer/2022110102/568142b1550346895daef2be/html5/thumbnails/26.jpg)
.
![Page 27: LINEZOLID](https://reader038.vdocuments.net/reader038/viewer/2022110102/568142b1550346895daef2be/html5/thumbnails/27.jpg)
.
CBC, Hb & Platelet count: particularly in patients who are at increased risk for bleeding, patients with pre-existing thrombocytopenia or Myelosuppression or concomitant medications that decrease platelet count or function or produce bone marrow suppression and in patient requiring more than 2 weeks therapy.Number and type of stools /day for diarrhea
![Page 28: LINEZOLID](https://reader038.vdocuments.net/reader038/viewer/2022110102/568142b1550346895daef2be/html5/thumbnails/28.jpg)
![Page 29: LINEZOLID](https://reader038.vdocuments.net/reader038/viewer/2022110102/568142b1550346895daef2be/html5/thumbnails/29.jpg)
Well tolerated by most patients.Same in children & adults
The most common adverse effects are:
Myelosuppression (1 to 10%) including anemia, pancytopenia, leucopenia & thrombocytopenia
Diarrhea (4 to 8%),
Headache, Insomnia, Dizziness (2 to 6%)
Nausea, vomiting (1 to 3.7%),
Altered taste or tongue discoloration (1 to 2%)
Transient elevation in liver function test (1 to 2%).
Pseudo membranous colitis
![Page 30: LINEZOLID](https://reader038.vdocuments.net/reader038/viewer/2022110102/568142b1550346895daef2be/html5/thumbnails/30.jpg)
.
![Page 31: LINEZOLID](https://reader038.vdocuments.net/reader038/viewer/2022110102/568142b1550346895daef2be/html5/thumbnails/31.jpg)
LINEZOLID is contraindicated for use in patients who have known hypersensitivity to Linezolid or any of the other product components.
.
![Page 32: LINEZOLID](https://reader038.vdocuments.net/reader038/viewer/2022110102/568142b1550346895daef2be/html5/thumbnails/32.jpg)
.
No dose adjustment is recommended
![Page 33: LINEZOLID](https://reader038.vdocuments.net/reader038/viewer/2022110102/568142b1550346895daef2be/html5/thumbnails/33.jpg)
.
No dose adjustment is recommended in case of mild & moderate hepatic insufficiency.
![Page 34: LINEZOLID](https://reader038.vdocuments.net/reader038/viewer/2022110102/568142b1550346895daef2be/html5/thumbnails/34.jpg)
.
Ingestion of Tyramine containing foods may cause hypertensive crisis.
Limit intake of Tyramine containing foods to less than 100 mg/meal
![Page 35: LINEZOLID](https://reader038.vdocuments.net/reader038/viewer/2022110102/568142b1550346895daef2be/html5/thumbnails/35.jpg)
Linezolid is not an inducer of cytochrome p450 (CYP). Therefore no CYP 450 induced drug interactions are expected. So the drugs like Warfarin and Phenytoin can be given without dose alteration. .
![Page 36: LINEZOLID](https://reader038.vdocuments.net/reader038/viewer/2022110102/568142b1550346895daef2be/html5/thumbnails/36.jpg)
.
Monoamine Oxidase inhibiter: It is a reversible non selective inhibitor of monoamine oxidase. Therefore, it has potential for interaction with adrenergic and serotonergic agents such as Tricyclic antidepressants, Detromethorpan and Trazodone.
![Page 37: LINEZOLID](https://reader038.vdocuments.net/reader038/viewer/2022110102/568142b1550346895daef2be/html5/thumbnails/37.jpg)
![Page 38: LINEZOLID](https://reader038.vdocuments.net/reader038/viewer/2022110102/568142b1550346895daef2be/html5/thumbnails/38.jpg)
Store reconstituted preparation at room temperature and use within 21 days. Store infusion bag in over wrap until
ready to use. The yellow color of infusion solution may intensify over time without adversely affecting the potency. Store at room temperature & protect
from light. Injection is compatible with D5, RL,
NS
![Page 39: LINEZOLID](https://reader038.vdocuments.net/reader038/viewer/2022110102/568142b1550346895daef2be/html5/thumbnails/39.jpg)
.
Avoid excessive amount of Tyramine containing foods; Red wine, Aged cheese, Smoked or pickled fish, Beef or chicken liver, dried sausage, fava or broad bean. Notify in case of persistent or
worsening of symptoms of infection, diarrhea, nausea or vomiting. Complete course of therapy even
if symptoms improve.
![Page 40: LINEZOLID](https://reader038.vdocuments.net/reader038/viewer/2022110102/568142b1550346895daef2be/html5/thumbnails/40.jpg)
![Page 41: LINEZOLID](https://reader038.vdocuments.net/reader038/viewer/2022110102/568142b1550346895daef2be/html5/thumbnails/41.jpg)
-Injection: 200mg (100 ml) 400mg (200 ml) 600mg (300 ml) Infuse over 30-120 mins. Do not infuse with any other medication. Flush IV line before & after infusion with compatible solution. - Suspension: Dry powder 20mg/ml Gently invert bottle 3-5 times. Do not shake. - Tablet: 400mg, 600mg
![Page 42: LINEZOLID](https://reader038.vdocuments.net/reader038/viewer/2022110102/568142b1550346895daef2be/html5/thumbnails/42.jpg)
![Page 43: LINEZOLID](https://reader038.vdocuments.net/reader038/viewer/2022110102/568142b1550346895daef2be/html5/thumbnails/43.jpg)
Linospan (Cipla) Linox (Unichem) Lizolid (Integrace) Lizomed
(Aglomed)
![Page 44: LINEZOLID](https://reader038.vdocuments.net/reader038/viewer/2022110102/568142b1550346895daef2be/html5/thumbnails/44.jpg)
![Page 45: LINEZOLID](https://reader038.vdocuments.net/reader038/viewer/2022110102/568142b1550346895daef2be/html5/thumbnails/45.jpg)